Synbiotics Corp. reported fourth-quarter earnings of $37,368...

Synbiotics Corp. reported fourth-quarter earnings of $37,368 on revenues of $743,958, an improvement from last year’s comparable $138,516 loss on revenues of $217,571. For the year ended March 31, the maker and marketer of monoclonal antibodies reported a loss of $1 million on revenue of $1.4 million. That compared to a loss last year of $849,525 on revenue of $916,701.